Open-Angle Glaucoma Drugs Market is Estimated to Witness High Growth Owing to Advancements in Novel Drug Delivery Modes

Glaucoma is a group of eye diseases which results in damage to the optic nerve and vision loss. Open-angle glaucoma is the most common form of glaucoma which accounts for about 90% of all glaucoma cases. The main treatment methods for open-angle glaucoma include topical eye drops such as prostaglandin analogs, beta blockers and alpha agonists. These eye drops help reduce pressure inside the eye and slow the progression of the disease when used as prescribed.

The open-angle glaucoma drugs market is estimated to be valued at USD 8.51 Bn in 2024 and is expected to reach USD 14.6 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8% from 2024 to 2031.

Key players operating in the Open-Angle Glaucoma Drugs are Pfizer, Santen, Merck, Allergan, Novartis, and Bausch Health.

Some of the key opportunities in the market include development of combination drugs, novel drug delivery systems and focus on expanding access to treatment in developing regions.

Technological advancements in drug delivery such as intraocular drug inserts and contact lenses as alternatives to eye drops are being explored to improve patient compliance and treatment outcomes.

Market drivers

The key driver propelling the growth of Open-Angle Glaucoma Drugs Market  is rising geriatric population globally which is more prone to developing glaucoma. It is estimated that over 60 million people suffer from open-angle glaucoma worldwide and this number is expected to increase further. With increasing life expectancy, the geriatric population affected by glaucoma will rise significantly. Other factors such as increasing awareness, availability of new treatment options and favorable reimbursement policies are also expected to boost the demand for glaucoma drugs over the forecast period.

Current Challenges in Open-Angle Glaucoma Drugs Market
As open-angle glaucoma is a chronic disease it requires long-term management with medications. Poor medication adherence is one of the major challenges faced by patients suffering from glaucoma. Additionally, many patients find it difficult to remember frequent instillation of eye drops. Side effects associated with glaucoma medications like burning sensation, temporary blurred vision also affects medication compliance in some cases. High cost of branded glaucoma drugs is another barrier especially in developing countries. Late diagnosis poses a treatment challenge as considerable damage may have already occurred to the optic nerve by the time disease is detected. Lack of symptoms at early stages makes regular eye screening important.

SWOT Analysis
Strength: Availability of wide range of glaucoma medications with different mechanisms of action aid in better management. Weakness: Frequent instillation and lifelong usage reduces medication adherence. Opportunity: Emergence of novel drug delivery technologies and devices help in enhancing treatment effectiveness. Threats: Increasing obesity prevalence raises risk of developing glaucoma posing public health challenge. Patent expiries of blockbuster drugs fuel competition.

North America currently accounts for the largest share in open-angle glaucoma drugs market owing to increasing prevalence of glaucoma, growing elderly population, strong healthcare infrastructure and availability of advanced treatment options. According to estimates, the US holds over 50% market share. Asia Pacific region is poised to witness fastest growth during the forecast period driven by improving access to diagnosis and treatment especially in emerging countries like China and India attributable to rising healthcare spending.

Europe holds significant market share majorly attributed to growing public awareness regarding glaucoma, government initiatives supporting ophthalmic research and availability of state-of-the-art glaucoma management facilities. However, affordability and access issues in low and middle-income countries limits market potential to some extent in these regions.

Get this Report in Japanese Language:  開放隅角緑内障治療薬市場

Get this Report in Korean Language: 개방각 녹내장 약물 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191 )